封面
市場調查報告書
商品編碼
2092386

生命科學測量設備市場(2025-2030年):市場概覽

The Life Science Instrumentation Market, 2025-2030: Market Briefs

出版日期: | 出版商: Strategic Directions International, Inc. | 英文 | 商品交期: 最快1-2個工作天內

價格
簡介目錄

「生命科學測量儀器市場(2025-2030)」報告旨在提供各類關鍵生命科學測量儀器的全面市場資訊。這份全面的市場概覽詳細介紹了生物製藥生產、管理和研發所需的關鍵儀器,以及用於基礎生命說明的儀器的市場機會、預期成長和主要趨勢。

這份全面的市場概覽涵蓋以下設備類別,包括市場規模、預測、趨勢、細分、市場佔有率和區域市場狀況:

  • 定序:DNA 和 RNA定序技術的進步極大地加速了許多領域的研究,包括分子生物學、疾病、藥物發現和總體基因體學。
  • PCR:核酸擴增,通常被稱為聚合酵素鏈鎖反應(PCR),是現代分子生物學中最具突破性的進展之一。這項技術最初於1986年問世,此後已成為所有DNA實驗室的必備工具。如今,PCR設備和試劑日益精密複雜。 PCR能夠檢測和擴增特定序列,從而利用單一模板產生數百萬個拷貝。
  • 微陣列:DNA微陣列是最常使用的微陣列技術,可用於DNA序列檢測(稱為比較基因組雜合反應,CGH)和基因表現評估。後者可用於測量基因表現量或比較兩個樣本之間的相對表現量。
  • 電泳:多年來,電泳一直是所有生物化學和分子生物學實驗室的重要工具。此方法利用均勻電場,根據大分子的大小和電荷,將DNA、RNA、蛋白質、胜肽及其片段等大分子分離。
  • 毛細管電泳:毛細管電泳是一系列分析技術,它根據帶電分子在不同施加電壓下的電泳遷移率來分離這些分子。隨著生物療法的發展,對生物分子進行高通量分析的需求也日益成長。
  • 表面等離子體共振(SPR)和無標定檢測:無標定(LF)檢測器或生物感測器廣泛應用於生命科學基礎研究和應用研究中,用於檢測和測量生物分析物。該技術無需使用螢光標記或其他標記物或標記劑,即可將生物反應轉化為可測量的訊號。
  • 流式細胞技術:流式細胞技術正日益與其他生命科學技術結合,包括次世代定序(NGS)應用。流式細胞儀可整合到高通量自動化工作流程中,是單細胞分析的理想選擇。它們也可用於分選經 CRISPR/Cas9 編輯的細胞。流式細胞技術儀不再只是免疫學工具;它們現在已融入生命科學研究的許多領域。
  • 高內涵分析/細胞影像:高內涵分析,也稱為高內涵篩檢(HCS) 或CELLOMICS,是一種用於細胞表現型篩檢的高通量技術。 HCS 系統結合了自動化高解析度數位顯微鏡、流式細胞技術和分析軟體,用於檢測細胞形態的變化並測量蛋白質合成的變化。
  • 電生理學:電生理學是研究生物系統電特性的學科。由於離子濃度的變化會引起電脈衝的產生,因此該領域的儀器旨在測量離子的流動。電生理學是闡明細胞如何對藥物和候選藥物產生反應的重要技術。
  • 自動化合成系統:寡核苷酸或胜肽的自動化合成系統無需初始模板即可在體外自動建立所需的DNA、RNA或蛋白質序列。這些高度擴充性的系統可在反應容器內以微莫耳至毫莫耳的濃度產生DNA或胜肽。
  • 體內動物影像:在候選藥物篩檢人體臨床試驗之前,需要先進行動物臨床前試驗。體內成像技術與其他方法和化學分析相結合,正迅速成為生命科學研究的標準技術。
  • 細胞計數器:自動化細胞計數器提供了一種準確且省時的細胞計數方法,可取代使用血球計數器或顯微鏡進行手動計數。手動計數方法耗時且容易出錯。這些系統通常用於細胞培養和細胞活力檢測。
  • 空間體學儀器:空間體學技術使研究人員能夠在完整組織中保留基因表現、蛋白質和其他生物分子的位置資訊的同時,對其進行分析。透過結合先進的成像、定序和分子譜分析技術,空間體學儀器能夠提供關於組織結構、細胞間相互作用和疾病機制的關鍵訊息,而這些資訊僅靠傳統的整體或單細胞分析是無法獲得的。這些系統正擴大應用於腫瘤學、神經科學、免疫學和藥物研發等領域,加深對複雜生物系統的理解,並支持精準醫療方法的發展。
簡介目錄
Product Code: 26-001SDI-BRIEF5

The Life Science Instrumentation Market, 2025-2030 is designed to provide total market knowledge for every significant life science instrumentation category. This comprehensive market brief details the market opportunity, expected growth and important trends in these essential instruments for manufacturing, control, research and development of biopharmaceutical therapies, as well as instruments used for basic life science research.

As part of its coverage, this comprehensive market brief includes market sizing, forecast, trends, segmentation, market share and geographic market description for the following instrumentation categories:

  • Sequencing: Developments in DNA and RNA sequencing technologies have significantly accelerated research in many areas, including molecular biology, disease, drug discovery, and metagenomics.
  • PCR: Nucleic acid amplification, commonly known as polymerase chain reaction (PCR), is one of the most revolutionary developments in modern molecular biology. The technique was introduced in its primitive form in 1986, and has since become an indispensable tool in all laboratories that work with DNA. Today, PCR instruments and reagents have become increasingly sophisticated. PCR enables the detection and amplification of a specific sequence, requiring only a single template to produce millions of copies.
  • Microarrays: DNA microarrays are the most commonly used, with applications in the detection of DNA sequences (referred to as comparative genomic hybridization or CGH), and the assessment of gene expression. The latter can be used to measure gene expression level, or to compare the relative expression levels between two samples.
  • Electrophoresis: Electrophoresis has long been an invaluable tool in every biochemistry and molecular biology lab. The technique uses a uniform electric field to separate macromolecules, such as DNA, RNA, proteins, peptides, and their fragments, based on their size and charge.
  • Capillary Electrophoresis: Capillary electrophoresis is a family of analytical techniques that separate charged molecules based on their electrophoretic mobility through applied voltage. As the development of biologics-based therapeutics grows, so does the need for high-throughput analysis of biomolecules.
  • SPR and Label-Free Detection: Label-free (LF) detection instruments, or biosensors, are used in basic and applied life science research for the detection or measurement of a biological analyte. The technique converts a biological response into a measurable signal without the aid of fluorescent labels or other tags and tagging agents.
  • Flow Cytometry: Flow cytometry is becoming increasingly integrated with other life sciences technologies, including NGS applications. Flow cytometers can be integrated into high-throughput robotic workflows, and are ideal for performing single cell analysis. They can even be used to sort cells which have undergone CRISPR/ CAS9 editing. Flow cytometry instruments are no longer just immunological tools, and are now integrated into many areas of life science research.
  • High Content Analysis/Cell Imaging: High-content analysis, also called high-content screening (HCS) or cellomics, is a high-throughput method of phenotypic screening conducted in cells. HCS systems incorporate automated high resolution digital microscopy, flow cytometry, and analysis software in order to detect changes in cell morphology and/or measure changes in protein synthesis.
  • Electrophysiology: Electrophysiology is the study of the electrical properties of biological systems. Because electrical impulses are generated by changes in ion concentrations, instruments in this field seek to measure ion flow. Electrophysiology is an important technique in characterizing how cells respond to drugs and drug candidates.
  • Automated Synthesizers: Automated synthesizer systems, for either oligonucleotides or peptides, are used to automatically build a desired sequence of DNA, RNA, or protein in vitro, without the need for an initial template. These scalable systems can produce quantities of DNA or peptides ranging from micromolar to millimolar in reaction vessels.
  • In Vivo Animal Imaging: Preclinical studies in animals are carried out before drug candidates are screened in human clinical trials. The use of in vivo imaging is swiftly becoming a standard technique in life science research, used in conjunction with other methods and chemical analyses.
  • Cell Counters: Automated cell counters provide an accurate, time-saving alternative to manual cell counting methods involving a hemocytometer and microscope, which are tedious and error-prone. These systems are typically employed in cell culture and cell viability assays.
  • Spatial Omics Instruments: Spatial omics technologies enable researchers to analyze gene expression, proteins, and other biological molecules while preserving their location within intact tissues. By combining advanced imaging, sequencing, and molecular profiling techniques, spatial omics instruments provide critical insights into tissue architecture, cellular interactions, and disease mechanisms that cannot be obtained through traditional bulk or single-cell analyses alone. These systems are increasingly used in oncology, neuroscience, immunology, and drug discovery research, driving a deeper understanding of complex biological systems and supporting the development of precision medicine approaches.